Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Prostate-specific antigen Stories

2012-06-04 02:26:08

BOTHELL, Wash. and VANCOUVER, British Columbia, June 4, 2012 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5. Preliminary results show a higher number of patients taking...

2012-06-02 23:01:52

The California Prostate Cancer Coalition Opposes US Task Force Prostate Cancer Testing Recommendation Century City, CA (PRWEB) June 02, 2012 The California Prostate Cancer Coalition (CPCC) is strongly opposing the U.S. Preventive Services Task Force´s (USPSTF) final recommendation (May 22, 2012) against the use of prostate-specific antigen (PSA) testing for the early detection of prostate cancer. The PSA test, used in conjunction with a digital rectal examination (DRE), is the only...

2012-05-31 02:26:49

BENTONVILLE, Ark., May 31, 2012 /PRNewswire/ -- June is Men's Health Month and with Father's Day just around the corner, Sam's Club Pharmacy locations invite you to show fathers and grandfathers how much you care by ensuring they are happy and healthy. Sam's Club observes Men's Health Month by offering free Men's Health Screenings on Saturday, June 9 from 11 a.m. to 3.p.m. Members and the public will receive a Prostate-Specific Antigen (PSA) test* to screen for accelerated PSA...

2012-05-30 05:26:23

(Ivanhoe Newswire) — Disease detectives at their best! Scientists have developed an ultra-sensitive test that should enable them to detect signs of a disease in its earliest stages. The test designed by scientists from Imperial College London and the University of Vigo detect particular molecules that indicate the presence of disease, even when these are in very low concentrations. "It is vital to detect diseases at an early stage if we want people to have the best possible...

2012-05-28 19:16:25

Scientists have developed an ultra-sensitive test that should enable them to detect signs of a disease in its earliest stages Scientists have developed an ultra-sensitive test that should enable them to detect signs of a disease in its earliest stages, in research published today in the journal Nature Materials. The scientists, from Imperial College London and the University of Vigo, have created a test to detect particular molecules that indicate the presence of disease, even when...

2012-05-28 09:48:07

Physicians have trouble stopping PSA tests, despite questionable benefits Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators. In a survey of 125 primary care doctors, the researchers found that while doctors agreed with...

2012-05-23 18:44:50

Studies on kidney stones, prostate cancer among highlights Mayo Clinic researchers will present findings on prostate cancer risk, screening, treatment and other urological research at the annual meeting of the American Urological Association May 19-23 in Atlanta. Mayo Clinic urologists will also be available to provide expert comment for reporters covering the conference. Mayo Clinic studies that will be presented and their embargo dates include: No negative impact on overall...

2012-05-23 06:25:52

NEW YORK, May 23, 2012 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics, today presented two clinical studies demonstrating the potential utility of non-invasive sampling of patients' urine to detect and manage prostate cancer. In the first study, the presence of a prostate cancer-specific biomarker in exosomes collected from random patients' urine samples demonstrated a strong...

Expert Medical Panel Urges Doctors To Stop PSA Cancer Screenings
2012-05-22 10:55:33

An expert US medical panel has given its final word on the PSA test, a controversial screening procedure used to detect prostate cancer in men, recommending that doctors should no longer perform the test on healthy men because they are more likely to be harmed by the test itself than be helped. The US Preventive Services Task Force (USPSTF) gave its recommendation on the stoppage of the PSA (prostate-specific antigen) test following a public comment period. It gave the test a D rating --...

2012-05-21 14:22:13

"D" Grading ignores benefits of screening in men known to be at high risk WASHINGTON, May 21, 2012 /PRNewswire-USNewswire/ -- The Prostate Cancer Roundtable expressed deep disappointment today as the U.S. Preventive Services Task Force (USPSTF) issued its final recommendation statement against the use of prostate-specific antigen (PSA) testing in the detection of prostate cancer. "A 'D' grade from the USPSTF will discourage many healthcare providers from using PSA testing at all; will...